[Cytopenias with dyshematopoiesis after hypoglycemic sulfamide treatment. Apropos of 3 cases].
D000328:Adult; D000740:Anemia / Q000139:chemically induced; D001772:Blood Cell Count; D001856:Bone Marrow Examination; D002271:Carbutamide / Q000009:adverse effects; D002747:Chlorpropamide / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced*; D006410:Hematopoiesis; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007970:Leukopenia / Q000139:chemically induced; D008103:Liver Cirrhosis / Q000150:complications; D008231:Lymphopenia / Q000139:chemically induced; D008297:Male; D008533:Megakaryocytes / Q000032:analysis; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D013453:Sulfonylurea Compounds / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D002271:Carbutamide; D002747:Chlorpropamide
Cytopénies avec dyshématopoïèse après traitement par sulfamides hypoglycémiants. A rpopos de trois observations.